Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Piperacillin-Tazobactam and Meropenem Plasmatic Levels in Critical Patients

NCT04257838 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.

NCT NCT04257838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04257838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Piperacillin-Tazobactam and Meropenem Plasmatic Levels in Critical Patients
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase
Observational
Overall status
Unknown status
Start date
February 15, 2020
Completion date
March 15, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock